Global Clinical Biomarkers Market Size Projected to Reach $52.67 Billion During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Clinical Biomarkers Industry Compare Between 2025 And 2029?

The clinical biomarkers market size has seen significant expansion in recent years. It is anticipated to expand from $30.78 billion in 2024 to $33.75 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.7%. This growth witnessed in prior periods can be attributed to several factors, including the increasing prevalence of chronic diseases, a heightened focus on personalized medicine and targeted therapies, advancements in drug development and clinical trials, and favorable regulatory support and funding.

The clinical biomarkers market size is anticipated to undergo significant expansion in the coming years, with projections indicating it will reach “$52.67 billion in 2029”, exhibiting a compound annual growth rate (CAGR) of 11.8%. This growth during the forecast period is primarily driven by the increasing expansion of companion diagnostics, a heightened emphasis on early diagnosis and disease prevention, broader applications in precision oncology and neurodegenerative diseases, and the rising prevalence of infectious diseases. Noteworthy trends for the forecast period encompass AI-powered biomarker discovery, the integration of machine learning, multi-omics integration, continuous technological innovations, and strategic partnerships among key industry participants.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12670&type=smp

Which Drivers Are Impacting The Clinical Biomarkers Market?

The substantial prevalence of cancer is anticipated to propel the future growth of the clinical biomarker market. Cancer describes a group of conditions where abnormal cells multiply and divide uncontrollably, potentially invading and harming healthy body tissues. Clinical biomarkers are critical in cancer prevention, assisting in early detection, risk assessment, and monitoring individuals at a high risk of developing the disease. For instance, according to Cancer Research UK, a UK-based cancer research organization, new kidney cancer cases are forecast to increase from approximately 16,300 between 2023 and 2025 to about 21,900 by 2038–2040, representing a 15% rise during this period. Therefore, the high incidence of cancer is a key driver for the expansion of the clinical biomarker market.

What Are The Different Segment Classifications Within The Clinical Biomarkers Market?

The clinical biomarkersmarket covered in this report is segmented –

1) By Offering: Product; Service

2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Immunohistochemistry (IHC); Enzyme-Linked Immunosorbent Assay (ELISA); Other Technologies

3) By Clinical Area: Cancer Biomarker; Cardiac Biomarker; Neurological Biomarker; Infectious Disease Biomarker; Immunological Biomarker; Non-Invasive Prenatal Testing; Other Clinical Areas

4) By Application: Clinical Diagnostic; Translational Research

5) By End User: Contract Research Organizations (CROs); Research And Academic Laboratories; Biopharmaceutical And Biotech Companies; Diagnostic Centers; Other End Users

Subsegments:

1) By Product: Diagnostic Kits; Reagents; Assay Kits; Instruments

2) By Service: Biomarker Discovery Services; Analytical Services; Clinical Trial Services; Data Analysis Services

What Trends Are Redefining The Clinical Biomarkers Market Dynamics?

Technological advancements represent a significant and expanding trend in the clinical biomarker market. Major companies operating within the clinical biomarker market are actively developing innovative technologies to maintain their standing. For instance, in June 2023, Veravas Inc., a US-based manufacturer specializing in medicinal products for enhancing laboratory medicine, unveiled its VeraBIND (Biomarker Isolation and N-enrichment for Detection) technology. This technology presents a uniquely innovative and comprehensive approach that boosts the precision of biomarker identification and reduces the probability of false positive or negative results across various sample types. By adopting this invention, clinical laboratories can enhance their diagnostic procedures and contribute to earlier disease detection, allowing for quick and targeted interventions. Moreover, VeraBIND facilitates faster assay creation, providing accuracy and consistency in studies, clinical studies, and diagnostic screenings.

Which Global Market Leaders Are Shaping The Future Of The Clinical Biomarkers Sector?

Major companies operating in the clinical biomarkers market include Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific, Agilent Technologies Inc., Epigenomics AG, Grifols S.A., Illumina Inc., BioMerieux SA., Charles River Laboratories International Inc., PerkinElmer Inc., Sartorius AG, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Luminex Corporation, Veracyte Inc., Centogene N.V., NanoString Technologies Inc., Enzo Biochem Inc., Biocartis Group NV, Agendia Inc., Siemens Healthcare Private Limited.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

What Regional Growth Trends Are Shaping The Clinical Biomarkers Market Outlook?

North America was the largest region in the clinical biomakers market in 2024. The regions covered in the clinical biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Clinical Biomarkers Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12670&type=smp

Browse Through More Reports Similar to the Global Clinical Biomarkers Market 2025, By The Business Research Company

Biomarkers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

Clinical Workflow Solutions Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-workflow-solutions-global-market-report

Clinical Nutritions Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-nutritions-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795